| Bill | HR 124 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 117 |
| Status | Archived — 117th Congress concluded |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Bill Title
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
Linked Goals
Steps
- 2021-01-04: Referred to the House Committee on Energy and Commerce.
- 2021-01-04: Introduced in House
- 2021-01-04: Introduced in House
- 2021-02-02: Referred to the Subcommittee on Health.
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.